DSIP (Delta Sleep-Inducing Peptide)

You can buy DSIP from Peptide Lab as a lab-verified research peptide with 99.0% purity and a Janoshik lab certificate for each batch. DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide — a chain of nine amino acids — which was discovered in the 1970s in connection with sleep. It is one of the best-known research peptides in the field of sleep and stress research and is supplied as a lyophilised powder, 10 mg per vial.

Who is DSIP intended for?

DSIP is intended for researchers and laboratories studying sleep patterns, stress adaptation and neuroendocrine processes. Related compounds can be found under Selank and Epithalon; see also the Sleep & Relaxation category.

Why Peptide Lab?

• Verified purity of 99.0% by HPLC and mass spectrometry.
• Public Certificate of Analysis per batch (JAN-2024-DSIP-0445).
• Lyophilised powder, 10 mg per vial.
• Fast, discreet EU delivery.

DSIP is not a medicinal product and is not intended for human or animal consumption.

Specifications at a glance

• Form: freeze-dried powder
• Packaging: 10 mg per vial
• Purity: 99.0%
• Molecular weight: 848.82 g/mol
• Laboratory certificate: JAN-2024-DSIP-0445
• For laboratory and research purposes only

DSIP is a small peptide consisting of nine amino acids with a molecular weight of approximately 848.82 g/mol. The name refers to delta waves: the slow brain waves characteristic of deep sleep.

Mechanism of action under investigation

DSIP was originally isolated because it was linked to the deep sleep phase in animal studies. In subsequent research, DSIP has been studied more extensively — not only in relation to sleep, but also to stress adaptation and the regulation of neuroendocrine processes. The exact mechanism of action has not yet been fully elucidated, which makes DSIP an interesting but complex subject of study.

These mechanisms are based on preclinical research and describe the research context; they do not represent proven effects in humans.

As a small, water-soluble peptide, DSIP is practical to work with in the laboratory. The nine amino acids form a well-defined, easily characterised structure, which helps to ensure that experiments can be set up in a reproducible manner.

The combination of a clear structure and a broad field of research makes DSIP a rewarding subject of study.

DSIP was first described in the 1970s by the researchers Schoenenberger and Monnier, who isolated it from brain tissue. Since then, it has been studied in a wide range of research projects.

• Research focus: delta sleep and sleep patterns (preclinical).
• Research focus: stress adaptation and neuroendocrine balance.
• Research focus: the mechanism of action, which is not yet fully understood.

Status of human research

DSIP has not been authorised as a medicinal product and research into it is largely at the pre-clinical stage; there are no established human clinical outcomes. As a research material, DSIP is intended solely for laboratory and research purposes. As the mechanism of action is still being investigated, a pure starting material and careful documentation are particularly important for reliable results.

The fact that its mechanism of action has still not been fully elucidated after decades makes DSIP both challenging and interesting: it demonstrates just how complex the regulation of sleep and stress is. In the literature, DSIP is often described as a peptide whose function appears to be broader than its original name suggests; findings are therefore treated with caution.

To ensure reliable research, the following applies: document the method, model and storage conditions for each experiment, so that results remain comparable across laboratories.

DSIP is supplied as a lyophilised powder and reconstituted in the laboratory using bacteriostatic water. The steps below describe only the laboratory procedures for research purposes.

1. 1Allow the vial and the bacteriostatic water to reach room temperature.
2. 2Wipe the rubber stoppers of both vials with an alcohol wipe.
3. 3Allow the bacteriostatic water to run slowly down the side of the vial; do not direct it straight onto the powder.
4. 4Gently swirl the vial until everything has dissolved; do not shake.
5. 5Store the solution in the fridge and label it with the date and batch number.

Items such as bacteriostatic water, insulin syringes and alcohol wipes can be found under ‘Lab & Accessories’. This is a laboratory instruction and does not constitute dosage advice for consumption.

Combining approaches in research

In the field of sleep and stress research, DSIP is sometimes studied alongside nootropic peptides such as Selank. Document each compound separately, specifying its purity and batch number, so that any observed effects can be traced back to the specific compound.

Working with a small peptide

With a small, soluble peptide, it is important to calculate the concentration accurately; make a note of this calculation for each experiment so that results remain comparable across sessions.

Store DSIP in powder form in a cool, dark place to ensure maximum stability.

Practical storage tips

• Powder form: freezer (-20 °C) for long-term storage; fridge (2–8 °C) for short-term storage.
• After reconstitution: store refrigerated (2–8 °C) and use within a few weeks.
• Avoid direct light, heat and repeated temperature changes.
• Write the reconstitution date and batch number on the vial.

Careful storage preserves the purity of the research material.

Consistent, cold storage helps to ensure reliable, reproducible measurement results.